Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Acutus Medical $170 million IPO
Davis Polk advised Acutus Medical, Inc. on its SEC-registered initial public offering of 10,147,058 shares of common stock…
Oak Street Health $377.3 million IPO
Davis Polk advised the joint book running managers in connection with the $377.3 million initial public offering of 17,968…
Rocket Companies $1.8 billion IPO and NYSE listing
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering by Rocket…
Linde $1 billion notes offering
Davis Polk advised the underwriters on the registered offering of $700 million aggregate principal amount of 1.100% notes…
Rocket Companies $1.8 billion IPO and NYSE listing
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering by Rocket…
Linde $1 billion notes offering
Davis Polk advised the underwriters on the registered offering of $700 million aggregate principal amount of 1.100% notes…
Turning Point Therapeutics $250 million at-the-market offering
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Turning Point Therapeutics, Inc. of its…
Tigermed HK$10.7 billion IPO and Hong Kong listing
Davis Polk advised Hangzhou Tigermed Consulting Co., Ltd. in connection with its initial public offering and listing on the…
Linde $1 billion notes offering
Davis Polk advised the underwriters on the registered offering of $700 million aggregate principal amount of 1.100% notes…
Turning Point Therapeutics $250 million at-the-market offering
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Turning Point Therapeutics, Inc. of its…